Predict your next investment

HEALTHCARE | Drug Development
alvillionllp.com

See what CB Insights has to offer

Business Relationships

4

Avillion Partners & Customers

4 Partners and customers

Avillion has 4 strategic partners and customers. Avillion recently partnered with Merck KGaA on September 9, 2020.

Date

Type

Business Partner

Country

News Snippet

Sources

9/10/2020

Partner

Merck KGaA

Germany

Avillion announces positive top-line results of Phase 2 trial of sonelokinab (M1095), an anti-IL-17 A/F Nanobody®, in chronic psoriasis

The trial was conducted by Avillion LLP under a 2017 co-development agreement with Merck KGaA Darmstadt , Germany under which Avillion LLP would undertake and finance the clinical development of sonelokinab of Merck KGaA Darmstadt , Germany , from Phase 2 through Phase 3 to regulatory submission .

1

3/13/2018

Partner

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

1/1/2017

Partner

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

12/5/2016

Partner

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

Date

9/10/2020

3/13/2018

1/1/2017

12/5/2016

Type

Partner

Partner

Partner

Partner

Business Partner

Merck KGaA

Country

Germany

Subscribe to see more

Subscribe to see more

Subscribe to see more

News Snippet

Avillion announces positive top-line results of Phase 2 trial of sonelokinab (M1095), an anti-IL-17 A/F Nanobody®, in chronic psoriasis

The trial was conducted by Avillion LLP under a 2017 co-development agreement with Merck KGaA Darmstadt , Germany under which Avillion LLP would undertake and finance the clinical development of sonelokinab of Merck KGaA Darmstadt , Germany , from Phase 2 through Phase 3 to regulatory submission .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

1

10

10

10

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.